1887

Journal of General Virology header logo

Volume 65, Issue 10

Inhibition by Indomethacin of Reactivation of Latent Herpes Simplex Virus Type 1 in Murine Trigeminal Ganglia Free

Abstract

SUMMARY

Infectious virus could no longer be detected in the trigeminal ganglia removed from mice 25 days after infection with herpes simplex virus type 1 (HSV-1) by the lip route. When the ganglia were cultured for 1 or 2 days, infectious HSV-1 was again detected in the ganglia, indicating the reactivation of latent HSV-1. The effect of indomethacin on this reactivation was examined. When the ganglia were cultivated in the presence of 5 × 10 -indomethacin, the appearance of infectious virus in the ganglia was almost completely inhibited. After removal of indomethacin, infectious virus appeared and the virus titre reached levels found in the ganglia cultured in indomethacin-free medium, indicating that the inhibition of the reactivation may not be due to the cytotoxic effect of indomethacin on the ganglionic cells. The inhibitory effect of indomethacin was only seen when it was added shortly after explantation. These results suggest that indomethacin affects some early processes of viral reactivation in the explanted ganglia. The synthesis of prostaglandins (PGE and PGB) found in the explanted ganglia was strongly suppressed by indomethacin, as was the viral reactivation. Other inhibitors of prostaglandin synthesis, i.e. tetracaine, mepacrine and mefenamic acid, also inhibited viral reactivation in the explanted ganglia. These results suggest that the inhibitory effect of indomethacin on the reactivation of latent HSV-1 may be due to the inhibition of prostaglandin synthesis, although it is possible that other cellular changes which could be caused by indomethacin contributed to the suppression of reactivation.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): HSV-1 , indomethacin , latent infection and reactivation
© Journal of General Virology 1984
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-10-1665
1984-10-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/10/JV0650101665.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-10-1665&mimeType=html&fmt=ahah

References

  1. Abe K., Yasujima M., Chiba S., Irokawa N., Ito T., Saito T., Yoshinaga K. 1977; Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 14:513–521
     [Google Scholar]
  2. Baringer I. R., Swoveland P. 1973; Recovery of herpes simplex virus from human trigeminal ganglions. New England Journal of Medicine 228:648–650
     [Google Scholar]
  3. Blyth W. A., Hill T. J., Field H. J., Arbour D. A. 1976; Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. Journal of General Virology 33:547–550
     [Google Scholar]
  4. Bradley P. B., Samuels G. M. R. 1971; Prostaglandins and chlorpromazine. Lancet ii:612
     [Google Scholar]
  5. Chang T. W. 1975; Suppression of herpetic recurrence by chlorpromazine. New England Journal of Medicine 293:153–154
     [Google Scholar]
  6. Cook M. L., Stevens J. G. 1973; Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intraaxonal transport of infection. Infection and Immunity 7:272–288
     [Google Scholar]
  7. Ferreira S. H., Moncada S., Vane J. R. 1971; Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biology 231:237–239
     [Google Scholar]
  8. Flower R. J., Blackwell G. J. 1976; The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochemical Pharmacology 25:285–291
     [Google Scholar]
  9. Flower R. J., Vane I. R. 1974; Inhibition of prostaglandin biosynthesis. Biochemical Pharmacology 23:1439–1450
     [Google Scholar]
  10. Galloway D. A., Fenoglio C., Shevchuk M., McDougall J. K. 1979; Detection of herpes simplex RNA in human sensory ganglia. Virology 95:265–268
     [Google Scholar]
  11. Greaves M. W., Sondergaard J. 1970; Pharmacologic agents released in ultraviolet inflammation studied by continuous skin perfusion. Journal of Investigative Dermatology 54:365–367
     [Google Scholar]
  12. Green M. T., Courtney R. J., Dunkel E. C. 1981a; Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infection and Immunity 34:987–992
     [Google Scholar]
  13. Green M. T., Rosborough J. P., Dunkel E. C. 1981b; In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model. Infection and Immunity 34:69–74
     [Google Scholar]
  14. Harbour D. A., Blyth W. A., Hill T. I. 1978; Prostaglandins enhance spread of herpes simplex virus in cell cultures. Journal of General Virology 41:87–95
     [Google Scholar]
  15. Harbour D. A., Hill T. J., Blyth W. A. 1983a; Prostaglandins enhance intercellular adhesion of Vero cells infected with herpes simplex virus. Journal of General Virology 64:507–512
     [Google Scholar]
  16. Harbour D. A., Hill T. J., Blyth W. A. 1983b; Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. Journal of General Virology 64:1491–1498
     [Google Scholar]
  17. Hill T. J. 1981; Mechanisms involved in recurrent herpes simplex. In The Human Herpesviruses: An Inter-disciplinary Perspective pp 241–244 Edited by Nahmias A. J., Dowdle W. R., Schinazi R. F. New York: Elsevier/North-Holland;
     [Google Scholar]
  18. Hill T. J., Blyth W. A. 1976; An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins. Lancet ii:397–399
     [Google Scholar]
  19. Hill T. J., Field H. J., Blyth W. A. 1975; Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28:341–353
     [Google Scholar]
  20. Hill T. J., Blyth W. A., Harbour D. A. 1978; Trauma to the skin causes recurrence of herpes simplex in the mouse. Journal of General Virology 39:21–28
     [Google Scholar]
  21. Jaffe B. M., Behrman H. R., Parker C. W. 1973; Radioimmunoassay measurement of prostaglandin E, A, and F in human plasma. Journal of Clinical Investigation 52:398–405
     [Google Scholar]
  22. Klein R. J., Friedman-Kien A. E., Brady E. 1978; Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site. Archives of Virology 57:161–166
     [Google Scholar]
  23. Lehner T., Wilton J. M. A., Shillitoe E. J. 1975; Immunological basis for latency, recurrences, and putative oncogenicity of herpes simplex virus. Lancet ii:60–62
     [Google Scholar]
  24. Merigan T. C. 1974; Host defenses against viral disease. New England Journal of Medicine 29:323–329
     [Google Scholar]
  25. Newton A. A. 1979; Inhibitors of prostaglandin synthesis as inhibitors of herpes simplex virus replication. Advances in Ophthalmology 38:58–63
     [Google Scholar]
  26. Newton A. A. 1982; Prostaglandins and the replication of herpes simplex type 1. In Herpesvirus: Clinical, Pharmacological and Basic Aspects pp 192–200 Edited by Shiota H., Cheng Y. C., Prusoff W. H. Amsterdam: Excerpta Medica;
     [Google Scholar]
  27. Openshaw H., Asher L. V. S., Wohlenberg C., Sekizawa T., Notkins A. L. 1979; Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. Journal of General Virology 44:205–215
     [Google Scholar]
  28. Openshaw H., Sekizawa T., Cantin E., Puga A., Notkins A. L. 1982; Latency and reactivation of herpes simplex virus: animal models. In Viral Infections in Oral Medicine pp 79–88 Edited by Hooks J. J., Jordan G. W. Amsterdam: Elsevier/North-Holland;
     [Google Scholar]
  29. Price R. W., Walz M. A., Wohlenberg C., Notkins A. L. 1975; Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science 188:938–940
     [Google Scholar]
  30. Puga A., Rosenthal J. D., Openshaw H., Notkins A. L. 1978; Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology 89:102–111
     [Google Scholar]
  31. Rubin R. P., Laychock S. G. 1978; Prostaglandins, calcium, and cyclic nucleotides in stimulus-response coupling. In Calcium in Drug Action pp 135–188 Edited by Weiss G. B. New York: Plenum Press;
     [Google Scholar]
  32. Scriba M. 1975; Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection. Infection and Immunity 12:162–165
     [Google Scholar]
  33. Sekizawa T., Openshaw H. 1984; Encephalitis resulting from reactivation of latent herpes simplex virus in mice. Journal of Virology 50:263–266
     [Google Scholar]
  34. Sekizawa T., Openshaw H., Wohlenberg C., Notkins A. L. 1980; Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation. Science 210:1026–1027
     [Google Scholar]
  35. Shimizu F., Shimizu Y., Kumagai K. 1976; Specific inactivation of herpes simplex virus by silver nitrate at low concentrations and biological activities of the inactivated virus. Antimicrobial Agents and Chemotherapy 10:57–63
     [Google Scholar]
  36. Stevens J. G., Cook M. L. 1971; Latent herpes simplex virus in spinal ganglia of mice. Science 173:843–845
     [Google Scholar]
  37. Thomas D. R., Philpott G. W., Jaffe B. M. 1974; The relationship between concentration of prostaglandin E and rates of cell replication. Experimental Cell Research 84:40–46
     [Google Scholar]
  38. Vargaftig B. B. 1977; Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors. Journal of Pharmacy and Pharmacology 29:222–228
     [Google Scholar]
  39. Walz M. A., Price R. W., Notkins A. L. 1974; Latent ganglionic infection with herpes simplex virus type 1 and 2: viral reactivation in vivo after neurectomy. Science 184:1185–1187
     [Google Scholar]
  40. Warren S. L., Carpenter C. M., Boak R. A. 1940; Symptomatic herpes, a sequela of artificially induced fever. Journal of Experimental Medicine 71:155–167
     [Google Scholar]
  41. Wohlenberg C., Openshaw H., Notkins A. L. 1979; In vitro system for studying the efficacy of antiviral agents in preventing the reactivation of latent herpes simplex virus. Antimicrobial Agents and Chemotherapy 15:625–627
     [Google Scholar]
  42. Yorio T., Bentley P. J. 1978; Phospholipase A and the mechanism of action of aldosterone. Nature, London 271:79–81
     [Google Scholar]
  43. Zusman R. M. 1972; Quantitative conversion of PGA or PGE to PGB. Prostaglandins 1:167–168
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-10-1665
Loading
Inhibition by Indomethacin of in vitro Reactivation of Latent Herpes Simplex Virus Type 1 in Murine Trigeminal Ganglia
J. Gen. Virol. 65, 1665 (1984); https://doi.org/10.1099/0022-1317-65-10-1665
/content/journal/jgv/10.1099/0022-1317-65-10-1665
/content/journal/jgv/10.1099/0022-1317-65-10-1665
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error